Phospho-GFAP(S8) Antibody Blocking peptide
€363.00
In stock
SKU
AC-BP3562a
Background:
GFAP is one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system.
Other Names:
Glial fibrillary acidic protein, GFAP, GFAP
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP3562a was selected from the region of human Phospho-GFAP-pS8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: GFAP
Gene ID: 2670
Primary Accession: P14136
Other Accession: NP_002046
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
GFAP is one of the major intermediate filament proteins of mature astrocytes. It is used as a marker to distinguish astrocytes from other glial cells during development. Mutations in this gene cause Alexander disease, a rare disorder of astrocytes in the central nervous system.
Other Names:
Glial fibrillary acidic protein, GFAP, GFAP
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP3562a was selected from the region of human Phospho-GFAP-pS8. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: GFAP
Gene ID: 2670
Primary Accession: P14136
Other Accession: NP_002046
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review